1. Home
  2. LSTA vs NBY Comparison

LSTA vs NBY Comparison

Compare LSTA & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTA
NBY
Founded
1980
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9M
31.6M
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
LSTA
NBY
Price
$3.14
$1.95
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
95.7K
324.4K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
20.42
35.42
EPS
N/A
0.76
Revenue
$35,283,868.00
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
56.90
N/A
52 Week Low
$1.81
$0.43
52 Week High
$5.07
$19.95

Technical Indicators

Market Signals
Indicator
LSTA
NBY
Relative Strength Index (RSI) 28.58 57.82
Support Level $1.91 $1.01
Resistance Level $4.95 $2.52
Average True Range (ATR) 0.31 0.26
MACD -0.11 0.11
Stochastic Oscillator 19.03 96.45

Price Performance

Historical Comparison
LSTA
NBY

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: